Abstract:A forefront of the research on Alzheimer's disease (AD) is the interaction of amyloid beta (A beta) peptides with redox metal ions (e.g., Cu(II), Fe(III), and Fe(II)) and the biological relevance of the A beta-metal complexes to neuronal cell loss and homeostasis of essential metals and other cellular species. This work is concerned with the kinetic and mechanistic studies of the ascorbic acid oxidation reaction by molecular oxygen that is facilitated by Cu(II) complexes with A beta(1-16), A beta(1-42), and aggregates of A beta(1-42). The reaction rate was found to linearly increase with the concentrations of A beta Cu(II) and dissolved oxygen and be invariant with high ascorbic acid concentrations. The rate constants were measured to be 117.2 +/- 15.4 and 15.8 +/- 2.8 M-1 s(-1) at low (<100 mu M) and high AA concentrations, respectively. Unlike free Cu(II), in the presence of AA. A beta Cu(II) complexes facilitate the reduction of oxygen by producing H2O2 as a major product. Such a conclusion is drawn on the basis that the reaction stoichiometry between AA and O-2 is 1:1 when the A beta concentration is kept at a much greater value than that of Cu(II). A mechanism is proposed for the AA oxidation in which the oxidation states of the copper center in the A beta complex alternates between 2+ and 1+. The catalytic activity of Cu(II) toward O-2 reduction was found to decrease in the order of free Cu(II) > A beta(1-16)-Cu(II) > A beta(1-42)-Cu(II) > Cu(II) complexed by the A beta oligomer/fibril mixture > Cu(II) in A beta fibrils. The finding that Cu(II) in oligomeric and fibrous A beta aggregates possesses considerable activity toward H2O2 generation is particularly significant, since in senile plaques of AD patients the coexisting copper and A beta aggregates have been suggested to inflict oxidative stress through the production of reactive oxygen species (ROS). Although Cu(II) hound to oligomeric and fibrous A beta aggregates is less effective than free Cu(II) and the monomeric A beta Cu(II) complex in producing ROS, in vivo the Cu(II)-containing A beta oligomers and fibrils might be more biologically relevant given their stronger association with cell membranes and the closer proximity of ROS to cell membranes.

Computational 3D Models of Fe 2+/3+ -Aβ 1-42 Complexes Associated with Alzheimer's Disease

Elucidating the 3D structures of Al(iii)-Aβ complexes: a template free strategy based on the pre-organization hypothesis

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies.

Multielement analysis of swiss mice brains with Alzheimer's disease induced by beta amyloid oligomers using a portable total reflection X- ray fluorescence system

Computational Study of Amyloidβ 42 Familial Mutations and Metal Interaction: Impact on Monomers and Aggregates Dynamical Behaviors

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Investigating Cu(I) binding to model peptides of N-terminal Aβ isoforms

Atomistic molecular simulations of Aβ-Zn conformational ensembles

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Structure Comparison of Beta Amyloid Peptide Aβ 1–42 Isoforms. Molecular Dynamics Modeling

A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions

Molecular Modeling Of Two Distinct Triangular Oligomers In Amyloid Beta-Protein

Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Redox behaviour of Cu-Aβ(4-16) complexes related to Alzheimer's Disease

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides